Urinary interleukin-9 in youth with type 1 diabetes mellitus.

"Declarations Conflict of interestThe authors declare that they have no competing interests. Consent for publicationNot applicable. Ethics approval and consent to participateInformed consent from each individual and their guardian was obtained for all participants. This research received approval from The Hospital for Sick Children, Research Ethics Board at the University of Toronto (ID# 1000012240). Conflict of interest The authors declare that they have no competing interests."

"Funding This AdDIT study is funded by the CIHR as part of the Can-SOLVE CKD Network. The AdDIT Study in Canada has received funding from the Juvenile Diabetes Research Foundation‒Canadian Clinical Trials Network, Canadian Diabetes Association, Heart and Stroke Foundation Canada and British Heart Foundation. Laura Motran helped with data collection. Dr. Semenchuk receives funds from the Department of Medicine at the University of Toronto. Dr. Sullivan receives funds from the Pediatric Scientist Development Program and the Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania Scholarship Award Program."